Abstract
To evaluate the potential usefulness of a single large oral dose of trimethoprim-sulfamethoxazole (TMP-SMZ) for the treatment of uncomplicated genitourinary gonorrhea, the pharmacokinetics of a 12-tablet dose containing 960 mg of TMP and 4,800 mg of SMZ were studied in 15 male volunteers, and the tolerance of this regimen was compared to that of a placebo in a double-blind crossover study. Both TMP and SMZ were rapidly absorbed. Peak mean serum concentrations (± standard deviation) of TMP, total SMZ, and free SMZ were 9.2 ± 2.2, 259.4 ± 40.9, and 233.7 ± 33.6 μg/ml, respectively. Elimination half-lives were 16.7, 14.6, and 12.9 h, respectively. When results were compared to data from similar studies after smaller doses, peak mean serum concentrations were proportional to dose, but elimination half-lives were longer after larger doses. Urinary concentrations of TMP, total SMZ, and free SMZ were many-fold higher than serum concentrations. Percents recovery (± standard deviation) in urine were 60.6 ± 10.6, 80.2 ± 7.8, and 37.4 ± 6.5%, respectively, during the 48 h after administration. The incidence of severe headache and of objective transient oliguria was significantly higher after TMP-SMZ than after placebo. Although the observed serum concentrations of TMP and SMZ surpassed concentrations necessary to inhibit clinical isolates of Neisseria gonorrhoeae in vitro for longer than 24 h, the adverse reactions associated with a 12-tablet dose of TMP-SMZ would preclude the clinical usefulness of such a therapeutic regimen.
Full text
PDF
Selected References
These references are in PubMed. This may not be the complete list of references from this article.
- Craig W. A., Kunin C. M. Trimethoprim-sulfamethoxazole: pharmacodynamic effects of urinary pH and impaired renal function. Studies in humans. Ann Intern Med. 1973 Apr;78(4):491–497. doi: 10.7326/0003-4819-78-4-491. [DOI] [PubMed] [Google Scholar]
- Duncan W. C., Knox J. M., Jackson T. H. Trimethoprim-sulfamethoxazole in the treatment of gonorrhea: comparison with standard treatment schedules. South Med J. 1975 Sep;68(9):1147–1152. doi: 10.1097/00007611-197509000-00020. [DOI] [PubMed] [Google Scholar]
- Meheus A. Z., Ngamije E., Freyens P. Treatment of gonorrhoea with trimethoprim-sulphamethoxazole and probenecid plus procaine penicillin in Rwanda. Br J Vener Dis. 1974 Dec;50(6):447–449. doi: 10.1136/sti.50.6.447. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Prior R. B., Fass R. J., Perkins R. L. Regression-line analysis of trimethoprim-sulfamethoxazole activity against Neisseria gonorrhoeae. Am J Clin Pathol. 1976 Sep;66(3):605–609. doi: 10.1093/ajcp/66.3.605. [DOI] [PubMed] [Google Scholar]
- Rahim G. Single-dose treatment of gonorrhoea with cotrimoxazole. A report on 1,223 cases. Br J Vener Dis. 1975 Jun;51(3):179–182. doi: 10.1136/sti.51.3.179. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Rodin P., Seth A. D. Treatment of gonorrhoea with cotrimoxazole, procaine penicillin alone, and procaine penicillin plus probenecid. Br J Vener Dis. 1972 Dec;48(6):517–521. doi: 10.1136/sti.48.6.517. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Schwartz D. E., Koechlin B. A., Weinfeld R. E. Spectrofluorimetric method for the determination of trimethoprim in body fluids. Chemotherapy. 1969;14(Suppl):22–29. doi: 10.1159/000220652. [DOI] [PubMed] [Google Scholar]
- Svindland H. B. Treatment of gonorrhoea with sulphamethoxazole-trimethoprim. Lack of effect on concomitant syphilis. Br J Vener Dis. 1973 Feb;49(1):50–53. doi: 10.1136/sti.49.1.50. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Yoshikawa T. T., Guze L. B. Concentrations of trimethoprim-sulfamethoxazole in blood after a single, large oral dose. Antimicrob Agents Chemother. 1976 Sep;10(3):462–463. doi: 10.1128/aac.10.3.462. [DOI] [PMC free article] [PubMed] [Google Scholar]